REIT - Industrial
Compare Stocks
5 / 10Stock Comparison
IIPR vs WELL vs VTR vs REFI vs OHI
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
REIT - Healthcare Facilities
REIT - Mortgage
REIT - Healthcare Facilities
IIPR vs WELL vs VTR vs REFI vs OHI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | REIT - Industrial | REIT - Healthcare Facilities | REIT - Healthcare Facilities | REIT - Mortgage | REIT - Healthcare Facilities |
| Market Cap | $1.62B | $149.25B | $41.15B | $245M | $13.74B |
| Revenue (TTM) | $263M | $11.63B | $6.13B | $44M | $1.24B |
| Net Income (TTM) | $120M | $1.43B | $260M | $4.87B | $632M |
| Gross Margin | 60.3% | 39.1% | -4.3% | 95.6% | 85.5% |
| Operating Margin | 46.7% | 4.4% | 13.4% | 18.4% | 64.3% |
| Forward P/E | 13.2x | 78.4x | 118.0x | 6.4x | 23.4x |
| Total Debt | $394M | $21.38B | $13.22B | $98M | $4.26B |
| Cash & Equiv. | $48M | $5.03B | $741M | $15M | $27M |
IIPR vs WELL vs VTR vs REFI vs OHI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Dec 21 | May 26 | Return |
|---|---|---|---|
| Innovative Industri… (IIPR) | 100 | 21.5 | -78.5% |
| Welltower Inc. (WELL) | 100 | 248.4 | +148.4% |
| Ventas, Inc. (VTR) | 100 | 169.3 | +69.3% |
| Chicago Atlantic Re… (REFI) | 100 | 69.8 | -30.2% |
| Omega Healthcare In… (OHI) | 100 | 155.9 | +55.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: IIPR vs WELL vs VTR vs REFI vs OHI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
IIPR ranks third and is worth considering specifically for income & stability.
- Dividend streak 9 yrs, beta 0.92, yield 13.5%
- 13.5% yield, 9-year raise streak, vs REFI's 100.0%
WELL has the current edge in this matchup, primarily because of its strength in long-term compounding and sleep-well-at-night.
- 223.1% 10Y total return vs IIPR's 436.4%
- Lower volatility, beta 0.13, Low D/E 49.5%, current ratio 5.34x
- 35.8% FFO/revenue growth vs IIPR's -13.8%
- +42.7% vs REFI's -7.9%
VTR is the clearest fit if your priority is growth exposure and defensive.
- Rev growth 18.5%, EPS growth 184.2%, 3Y rev CAGR 12.2%
- Beta 0.01, yield 2.1%, current ratio 0.96x
- Beta 0.01 vs IIPR's 0.92
REFI is the #2 pick in this set and the best alternative if value and quality is your priority.
- Lower P/E (6.4x vs 118.0x)
- 109.7% margin vs VTR's 4.2%
OHI is the clearest fit if your priority is valuation efficiency.
- PEG 1.00 vs IIPR's 3.52
- 6.1% ROA vs VTR's 1.0%, ROIC 6.0% vs 2.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 35.8% FFO/revenue growth vs IIPR's -13.8% | |
| Value | Lower P/E (6.4x vs 118.0x) | |
| Quality / Margins | 109.7% margin vs VTR's 4.2% | |
| Stability / Safety | Beta 0.01 vs IIPR's 0.92 | |
| Dividends | 13.5% yield, 9-year raise streak, vs REFI's 100.0% | |
| Momentum (1Y) | +42.7% vs REFI's -7.9% | |
| Efficiency (ROA) | 6.1% ROA vs VTR's 1.0%, ROIC 6.0% vs 2.5% |
IIPR vs WELL vs VTR vs REFI vs OHI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
IIPR vs WELL vs VTR vs REFI vs OHI — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
REFI leads in 3 of 6 categories
WELL leads 1 • IIPR leads 0 • VTR leads 0 • OHI leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
REFI leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
WELL is the larger business by revenue, generating $11.6B annually — 262.2x REFI's $44M. REFI is the more profitable business, keeping 109.7% of every revenue dollar as net income compared to VTR's 4.2%. On growth, WELL holds the edge at +40.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $263M | $11.6B | $6.1B | $44M | $1.2B |
| EBITDAEarnings before interest/tax | $197M | $2.8B | $2.3B | $8M | $1.1B |
| Net IncomeAfter-tax profit | $120M | $1.4B | $260M | $4.9B | $632M |
| Free Cash FlowCash after capex | $144M | $2.5B | $1.4B | $3.2B | $912M |
| Gross MarginGross profit ÷ Revenue | +60.3% | +39.1% | -4.3% | +95.6% | +85.5% |
| Operating MarginEBIT ÷ Revenue | +46.7% | +4.4% | +13.4% | +18.4% | +64.3% |
| Net MarginNet income ÷ Revenue | +45.6% | +12.3% | +4.2% | +109.7% | +51.0% |
| FCF MarginFCF ÷ Revenue | +54.7% | +21.9% | +22.4% | +71.8% | +73.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | -3.8% | +40.3% | +22.0% | -100.0% | +16.7% |
| EPS Growth (YoY)Latest quarter vs prior year | -1.0% | +22.5% | 0.0% | -51.1% | +42.4% |
Valuation Metrics
REFI leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 6.9x trailing earnings, REFI trades at a 96% valuation discount to VTR's 160.3x P/E. Adjusting for growth (PEG ratio), OHI offers better value at 1.02x vs IIPR's 3.85x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $1.6B | $149.2B | $41.1B | $245M | $13.7B |
| Enterprise ValueMkt cap + debt − cash | $2.0B | $165.6B | $53.6B | $328M | $18.0B |
| Trailing P/EPrice ÷ TTM EPS | 14.40x | 153.25x | 160.26x | 6.92x | 23.78x |
| Forward P/EPrice ÷ next-FY EPS est. | 13.17x | 78.42x | 118.01x | 6.41x | 23.40x |
| PEG RatioP/E ÷ EPS growth rate | 3.85x | — | — | — | 1.02x |
| EV / EBITDAEnterprise value multiple | 9.91x | 66.40x | 24.31x | 9.12x | 16.72x |
| Price / SalesMarket cap ÷ Revenue | 6.08x | 13.99x | 7.05x | 3.88x | 11.47x |
| Price / BookPrice ÷ Book value/share | 0.87x | 3.35x | 3.18x | 0.81x | 2.63x |
| Price / FCFMarket cap ÷ FCF | 9.26x | 52.41x | 31.25x | 0.01x | 15.64x |
Profitability & Efficiency
REFI leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
OHI delivers a 11.9% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $2 for VTR. IIPR carries lower financial leverage with a 0.21x debt-to-equity ratio, signaling a more conservative balance sheet compared to VTR's 1.05x. On the Piotroski fundamental quality scale (0–9), WELL scores 7/9 vs IIPR's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +6.4% | +3.5% | +2.1% | +6.4% | +11.9% |
| ROA (TTM)Return on assets | +5.1% | +2.3% | +1.0% | +4.5% | +6.1% |
| ROICReturn on invested capital | +4.3% | +0.5% | +2.5% | +6.9% | +6.0% |
| ROCEReturn on capital employed | +5.8% | +0.6% | +3.2% | +9.3% | +7.9% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 7 | 6 | 5 | 6 |
| Debt / EquityFinancial leverage | 0.21x | 0.49x | 1.05x | 0.32x | 0.78x |
| Net DebtTotal debt minus cash | $346M | $16.3B | $12.5B | $83M | $4.2B |
| Cash & Equiv.Liquid assets | $48M | $5.0B | $741M | $15M | $27M |
| Total DebtShort + long-term debt | $394M | $21.4B | $13.2B | $98M | $4.3B |
| Interest CoverageEBIT ÷ Interest expense | 6.67x | 0.26x | 1.40x | 4.77x | 3.83x |
Total Returns (Dividends Reinvested)
WELL leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WELL five years ago would be worth $30,234 today (with dividends reinvested), compared to $4,999 for IIPR. Over the past 12 months, WELL leads with a +42.7% total return vs REFI's -7.9%. The 3-year compound annual growth rate (CAGR) favors WELL at 42.5% vs IIPR's 4.5% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +18.3% | +14.3% | +12.6% | -1.4% | +6.6% |
| 1-Year ReturnPast 12 months | +20.3% | +42.7% | +33.9% | -7.9% | +36.9% |
| 3-Year ReturnCumulative with dividends | +14.1% | +189.5% | +94.2% | +25.7% | +86.2% |
| 5-Year ReturnCumulative with dividends | -50.0% | +202.3% | +74.8% | +24.7% | +63.1% |
| 10-Year ReturnCumulative with dividends | +436.4% | +223.1% | +65.0% | +24.7% | +110.0% |
| CAGR (3Y)Annualised 3-year return | +4.5% | +42.5% | +24.8% | +7.9% | +23.0% |
Risk & Volatility
Evenly matched — VTR and OHI each lead in 1 of 2 comparable metrics.
Risk & Volatility
OHI is the less volatile stock with a -0.13 beta — it tends to amplify market swings less than IIPR's 0.92 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. VTR currently trades 97.8% from its 52-week high vs REFI's 76.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.92x | 0.13x | 0.01x | 0.69x | -0.13x |
| 52-Week HighHighest price in past year | $61.40 | $219.59 | $88.50 | $15.20 | $49.14 |
| 52-Week LowLowest price in past year | $44.58 | $142.65 | $61.76 | $10.74 | $35.09 |
| % of 52W HighCurrent price vs 52-week peak | +92.2% | +97.0% | +97.8% | +76.4% | +93.9% |
| RSI (14)Momentum oscillator 0–100 | 59.3 | 60.2 | 56.2 | 58.1 | 48.6 |
| Avg Volume (50D)Average daily shares traded | 303K | 2.6M | 3.4M | 167K | 1.9M |
Analyst Outlook
Evenly matched — IIPR and REFI each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: IIPR as "Hold", WELL as "Buy", VTR as "Buy", REFI as "Buy", OHI as "Hold". Consensus price targets imply 20.5% upside for REFI (target: $14) vs -22.3% for IIPR (target: $44). For income investors, REFI offers the higher dividend yield at 100.00% vs WELL's 1.30%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $44.00 | $226.50 | $90.80 | $14.00 | $49.14 |
| # AnalystsCovering analysts | 11 | 34 | 32 | 6 | 28 |
| Dividend YieldAnnual dividend ÷ price | +13.5% | +1.3% | +2.1% | +100.0% | +5.4% |
| Dividend StreakConsecutive years of raises | 9 | 2 | 1 | 1 | 0 |
| Dividend / ShareAnnual DPS | $7.62 | $2.76 | $1.86 | $2045.71 | $2.51 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.2% | 0.0% | 0.0% | 0.0% | 0.0% |
REFI leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). WELL leads in 1 (Total Returns). 2 tied.
IIPR vs WELL vs VTR vs REFI vs OHI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is IIPR or WELL or VTR or REFI or OHI a better buy right now?
For growth investors, Welltower Inc.
(WELL) is the stronger pick with 35. 8% revenue growth year-over-year, versus -13. 8% for Innovative Industrial Properties, Inc. (IIPR). Chicago Atlantic Real Estate Finance, Inc. (REFI) offers the better valuation at 6. 9x trailing P/E (6. 4x forward), making it the more compelling value choice. Analysts rate Welltower Inc. (WELL) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — IIPR or WELL or VTR or REFI or OHI?
On trailing P/E, Chicago Atlantic Real Estate Finance, Inc.
(REFI) is the cheapest at 6. 9x versus Ventas, Inc. at 160. 3x. On forward P/E, Chicago Atlantic Real Estate Finance, Inc. is actually cheaper at 6. 4x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Omega Healthcare Investors, Inc. wins at 1. 00x versus Innovative Industrial Properties, Inc. 's 3. 52x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — IIPR or WELL or VTR or REFI or OHI?
Over the past 5 years, Welltower Inc.
(WELL) delivered a total return of +202. 3%, compared to -50. 0% for Innovative Industrial Properties, Inc. (IIPR). Over 10 years, the gap is even starker: IIPR returned +436. 4% versus REFI's +24. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — IIPR or WELL or VTR or REFI or OHI?
By beta (market sensitivity over 5 years), Omega Healthcare Investors, Inc.
(OHI) is the lower-risk stock at -0. 13β versus Innovative Industrial Properties, Inc. 's 0. 92β — meaning IIPR is approximately -815% more volatile than OHI relative to the S&P 500. On balance sheet safety, Innovative Industrial Properties, Inc. (IIPR) carries a lower debt/equity ratio of 21% versus 105% for Ventas, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — IIPR or WELL or VTR or REFI or OHI?
By revenue growth (latest reported year), Welltower Inc.
(WELL) is pulling ahead at 35. 8% versus -13. 8% for Innovative Industrial Properties, Inc. (IIPR). On earnings-per-share growth, the picture is similar: Ventas, Inc. grew EPS 184. 2% year-over-year, compared to -28. 8% for Innovative Industrial Properties, Inc.. Over a 3-year CAGR, WELL leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — IIPR or WELL or VTR or REFI or OHI?
Chicago Atlantic Real Estate Finance, Inc.
(REFI) is the more profitable company, earning 57. 1% net margin versus 4. 3% for Ventas, Inc. — meaning it keeps 57. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: OHI leads at 62. 6% versus 3. 3% for WELL. At the gross margin level — before operating expenses — IIPR leads at 88. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is IIPR or WELL or VTR or REFI or OHI more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Omega Healthcare Investors, Inc. (OHI) is the more undervalued stock at a PEG of 1. 00x versus Innovative Industrial Properties, Inc. 's 3. 52x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Chicago Atlantic Real Estate Finance, Inc. (REFI) trades at 6. 4x forward P/E versus 118. 0x for Ventas, Inc. — 111. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for REFI: 20. 5% to $14. 00.
08Which pays a better dividend — IIPR or WELL or VTR or REFI or OHI?
All stocks in this comparison pay dividends.
Chicago Atlantic Real Estate Finance, Inc. (REFI) offers the highest yield at 100. 0%, versus 1. 3% for Welltower Inc. (WELL).
09Is IIPR or WELL or VTR or REFI or OHI better for a retirement portfolio?
For long-horizon retirement investors, Omega Healthcare Investors, Inc.
(OHI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 13), 5. 4% yield, +110. 0% 10Y return). Both have compounded well over 10 years (OHI: +110. 0%, REFI: +24. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between IIPR and WELL and VTR and REFI and OHI?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: IIPR is a small-cap deep-value stock; WELL is a mid-cap high-growth stock; VTR is a mid-cap high-growth stock; REFI is a small-cap high-growth stock; OHI is a mid-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.